References
- Peters M. J., Van Der Horst‐Bruinsma I. E., Dijkmans B. A., Nurmohamed M. T. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004; 34: 585–92
- Slobodin G., Naschitz J. E., Zuckerman E., Zisman D., Rozenbaum M., Boulman N., et al. Aortic involvement in rheumatic diseases. Clin Exp Rheumatol 2006; 24: S41–7
- Bulkley B. H., Roberts W. C. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation 1973; 48: 1014–27
- Huffer L. L., Furgerson J. L. Aortic root dilatation with sinus of valsalva and coronary artery aneurysms associated with ankylosing spondylitis. Tex Heart Inst J 2006; 33: 70–3
- Malesci D., Niglio A., Mennillo G. A., Buono R., Valentini G., La Montagna G. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 2007; 26: 710–14
- Divecha H., Sattar N., Rumley A., Cherry L., Lowe G. D., Sturrock R. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non‐inflammatory control subjects: relevance of systemic inflammation. Clin Sci 2005; 109: 171–6
- Han C., Robinson DW J. r., Hackett M. V., Paramore L. C., Fraeman K. H., Bala M. V. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006; 33: 2167–72
- Christophers E. Comorbidities in psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 52–5
- Gelfand J. M., Neimann A. L., Shin D. B., Wang X., Margolis D. J., Troxel A. B. Risk of myocardial infarction in patients with psoriasis. J Am Med Assoc 2006; 296: 1735–41
- Sari I., Okan T., Akar S., Cece H., Altay C., Secil M., et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 2006; 45: 283–6
- Heeneman S., Daemen M. J. Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol 2007; 19: 358–62
- Kremers H. M., McEvoy M. T., Dann F. J., Gabriel S. E. Heart disease in psoriasis. J Am Acad Dermatol 2007; 57: 347–54
- Gonzalez‐Juanatey C., Llorca J., Miranda‐Filloy J. A., Amigo‐Diaz E., Testa A., Garcia‐Porrua C., et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007; 57: 287–93
- Haskard D. O. Accelerated atherosclerosis in inflammatory rheumatic diseases. Scand J Rheumatol 2004; 33: 281–92
- van der Linden S., Valkenburg H. A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361–8
- Moll J. M., Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 55–78
- Bakland G., Nossent H. C., Gran J. T. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum 2005; 53: 850–5
- Hollan I., Scott H., Saatvedt K., Prayson R., Mikkelsen K., Nossent H., et al. Inflammatory rheumatic disease and smoking predict aortic inflammation. Arthritis Rheum 2007; 56: 2072–9